Eva Hadaschik - Concepedia

Author

Eva Hadaschik

Also Known As

Aspelmeier, Timo, E Hadaschik, E. Hadaschik, E.N. Hadaschik, Eva Hadaschik, Eva N Hadaschik, Eva N. Hadaschik, Schmidt, Enno

241

Publications

1.9K

Citations

H-Index

Concepts

All Affiliations

Heidelberg University University of Duisburg-Essen Essen University Hospital University Hospital Heidelberg German Cancer Research Center

About

Eva Hadaschik is an author at Heidelberg University specializing in medicine, immunology, and dermatology.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	18	25	764
2	Health Sciences	3	3	88
3	Allergy	3	3	70
4	Engineering	2	2	45
5	Natural Sciences	1	1	13

Eva Hadaschik

Publications

1.4K

Citations

H-Index

Page 1

	Year	Citations
Regulatory T-cell deficiency leads to pathogenic bullous pemphigoid antigen 230 autoantibody and autoimmune bullous disease Stefanie Haeberle, Xiaoying Wei, Katja Bieber, Journal of Allergy and Clinical Immunology ImmunogeneticsAutoimmune DiseaseAutoantibody ProductionImmunodeficienciesPathogenesis	2018	93
Drug-induced sarcoidosis-like reaction in adjuvant immunotherapy: Increased rate and mimicker of metastasis Eleftheria Chorti, Theodora Kanaki, Lisa Zimmer, European Journal of Cancer Drug-induced Sarcoidosis-like ReactionAdjuvant ImmunotherapyMedicineImmunologyImmune Checkpoint Inhibitor	2020	71
European Guidelines (S1) on the use of high‐dose intravenous immunoglobulin in dermatology Alexander Enk, Eva Hadaschik, Rüdiger Eming, Journal of the European Academy of Dermatology and Venereology	2016	65
Regulatory T cell-deficient scurfy mice develop systemic autoimmune features resembling lupus-like disease Eva Hadaschik, Xiaoying Wei, H. Leiss, Arthritis Research & Therapy ImmunogeneticsLupus-like DiseaseAutoimmune DiseaseLupusT-regulatory Cell	2015	64
Autoantibodies in psoriasis as predictors for loss of response and anti-infliximab antibody induction Jochen Hoffmann, Mechthild Hartmann, Alexander Enk, British Journal of Dermatology	2011	63
Impact of American Joint Committee on Cancer 8th edition classification on staging and survival of patients with melanoma Theodora Kanaki, Andreas Stang, Ralf Gutzmer, European Journal of Cancer Surgical OncologyMedicineAmerican Joint CommitteeCancer ManagementMelanoma	2019	55
Correlation of tumor PD-L1 expression in different tissue types and outcome of PD-1-based immunotherapy in metastatic melanoma – analysis of the DeCOG prospective multicenter cohort study ADOREG/TRIM Jan‐Malte Placke, Mona Kimmig, Klaus Griewank, EBioMedicine	2023	43
Clinical and genetic analysis of melanomas arising in acral sites Anne Zaremba, Rajmohan Murali, Philipp Jansen, European Journal of Cancer Acral SitesPhotocarcinogenesisSurgical PathologyMelanomaPathology	2019	42
Analysis of High-dose Intravenous Immunoglobulin Therapy in 16 Patients with Refractory Autoimmune Blistering Skin Disease: High Efficacy and No Serious Adverse Events V Seidling, Jochen Hoffmann, A Enk, Acta Dermato Venereologica ImmunologyDermatologyImmunotherapyAutoantibodiesIvig Therapy	2013	40
Scleromyxoedema: Clinical Follow-up After Successful Treatment with High-dose Immunoglobulins Reveals Different Long-term Outcomes Mona Bidier, C Zschoche, Patrick Gholam, Acta Dermato Venereologica Autoimmune DiseaseSclerodermaClinical Follow-upSuccessful TreatmentImmunodeficiencies	2012	39

Page 1